First Time Loading...

Oyster Point Pharma Inc
NASDAQ:OYST

Watchlist Manager
Oyster Point Pharma Inc Logo
Oyster Point Pharma Inc
NASDAQ:OYST
Watchlist
Price: 11.17 USD Market Closed
Updated: May 3, 2024

Oyster Point Pharma Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oyster Point Pharma Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Oyster Point Pharma Inc
NASDAQ:OYST
Net Income (Common)
-$100.7m
CAGR 3-Years
-83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$4.8B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$484m
CAGR 3-Years
17%
CAGR 5-Years
-39%
CAGR 10-Years
-20%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Oyster Point Pharma Inc's Net Income (Common)?
Net Income (Common)
-100.7m USD

Based on the financial report for Dec 31, 2021, Oyster Point Pharma Inc's Net Income (Common) amounts to -100.7m USD.

What is Oyster Point Pharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-83%

Over the last year, the Net Income (Common) growth was -43%. The average annual Net Income (Common) growth rates for Oyster Point Pharma Inc have been -83% over the past three years .